Van Cleef Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$553K Hold
1,572
0.06% 83
2025
Q4
$515K Buy
1,572
+50
+3% +$15.9K 0.05% 86
2025
Q3
$430K Sell
1,522
-20
-1% -$5.8K 0.04% 90
2025
Q2
$431K Sell
1,542
-100
-6% -$28.3K 0.05% 88
2025
Q1
$512K Sell
1,642
-40
-2% -$11.8K 0.06% 82
2024
Q4
$438K Sell
1,682
-330
-16% -$97.9K 0.05% 87
2024
Q3
$648K Sell
2,012
-15
-0.7% -$4.91K 0.07% 74
2024
Q2
$633K Hold
2,027
0.08% 67
2024
Q1
$576K Buy
2,027
+330
+19% +$96.6K 0.07% 74
2023
Q4
$489K Hold
1,697
0.07% 73
2023
Q3
$456K Hold
1,697
0.07% 73
2023
Q2
$377K Sell
1,697
-148
-8% -$34.3K 0.06% 80
2023
Q1
$446K Hold
1,845
0.07% 76
2022
Q4
$485K Sell
1,845
-220
-11% -$59K 0.08% 75
2022
Q3
$465K Hold
2,065
0.09% 71
2022
Q2
$502K Sell
2,065
-1,655
-44% -$406K 0.09% 72
2022
Q1
$900K Sell
3,720
-250
-6% -$57.4K 0.13% 62
2021
Q4
$893K Sell
3,970
-375
-9% -$79.1K 0.13% 64
2021
Q3
$924K Hold
4,345
0.14% 60
2021
Q2
$1.06M Hold
4,345
0.16% 59
2021
Q1
$1.08M Buy
4,345
+330
+8% +$78.7K 0.17% 58
2020
Q4
$923K Hold
4,015
0.15% 61
2020
Q3
$1.02M Hold
4,015
0.19% 54
2020
Q2
$947K Sell
4,015
-113
-3% -$25.8K 0.19% 54
2020
Q1
$837K Hold
4,128
0.21% 55
2019
Q4
$995K Hold
4,128
0.2% 63
2019
Q3
$799K Sell
4,128
-1,100
-21% -$211K 0.18% 65
2019
Q2
$963K Buy
5,228
+300
+6% +$53.7K 0.21% 55
2019
Q1
$936K Hold
4,928
0.22% 58
2018
Q4
$959K Buy
4,928
+320
+7% +$62.4K 0.26% 52
2018
Q3
$955K Sell
4,608
-640
-12% -$126K 0.21% 52
2018
Q2
$969K Buy
5,248
+85
+2% +$15K 0.23% 50
2018
Q1
$880K Buy
5,163
+75
+1% +$13.8K 0.22% 57
2017
Q4
$885K Sell
5,088
-200
-4% -$35.4K 0.22% 61
2017
Q3
$986K Hold
5,288
0.27% 52
2017
Q2
$911K Hold
5,288
0.27% 52
2017
Q1
$868K Hold
5,288
0.26% 54
2016
Q4
$773K Buy
5,288
+100
+2% +$15.1K 0.25% 58
2016
Q3
$865K Sell
5,188
-50
-1% -$8.46K 0.29% 51
2016
Q2
$797K Buy
5,238
+50
+1% +$7.77K 0.27% 55
2016
Q1
$778K Hold
5,188
0.28% 55
2015
Q4
$842K Hold
5,188
0.31% 52
2015
Q3
$718K Hold
5,188
0.28% 55
2015
Q2
$796K Hold
5,188
0.3% 53
2015
Q1
$829K Hold
5,188
0.31% 51
2014
Q4
$826K Buy
5,188
+313
+6% +$48.8K 0.31% 53
2014
Q3
$685K Hold
4,875
0.28% 51
2014
Q2
$577K Buy
4,875
+300
+7% +$34.7K 0.24% 58
2014
Q1
$564K Hold
4,575
0.25% 54
2013
Q4
$522K Hold
4,575
0.23% 59
2013
Q3
$512K Hold
4,575
0.25% 55
2013
Q2
$451K Buy
+4,575
New +$475K 0.24% 59

Other funds holding AMGN

Van Cleef Asset Management's AMGN Position: Q1 2026 in Review

Van Cleef Asset Management held its Amgen (AMGN) position steady in Q1 2026 at 1,572 shares worth $553K. The position accounts for 0.06% of the portfolio, ranked #83.

Van Cleef Asset Management first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.08M in Q1 2021. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Van Cleef Asset Management held 1,572 shares of Amgen worth $553K as of Q1 2026.
  • Van Cleef Asset Management left its Amgen share count unchanged in Q1 2026.
  • Amgen made up 0.06% of Van Cleef Asset Management's portfolio in Q1 2026, its #83 holding.
  • Van Cleef Asset Management first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • Van Cleef Asset Management's Amgen position peaked at $1.08M in Q1 2021.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Van Cleef Asset Management's 13F filing for Q1 2026, filed 1 May 2026.